Stockreport

Pipeline Moves: Investigator-led trial of Lilly's merestinib in solid tumours terminated [Yahoo! Finance]

Leap Therapeutics, Inc.  (LPTX) 
Last leap therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.leaptx.com
PDF Meanwhile, RevImmune terminated a Phase II trial of its Mycobacterium avium infection candidate CYT-107 and a Phase II investigator-led trial of Leap Therapeutics sirex [Read more]